Beta-Site APP-Cleaving Enzyme 2 (CT) Blocking Peptide

Contact us
Leinco Technologies
Product Code: LEI-B366
Product Group: Peptides
CodeSizePrice
LEI-B366-50ug50 ug£216.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
Ambient
Storage:
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.

Further Information

Concentration:
0.2 mg/ml
Format:
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Formulation:
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Long Description:
Beta-Site APP-Cleaving Enzyme 2 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.
Target:
Beta-Site Amyloid Precursor Protein Cleaving Enzyme 2

References

1. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21 2. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC . Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-4 3. Kobayashi K, Hatano M, Otaki M, Ogasawara T, Tokuhisa T. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc Natl Acad Sci USA 1999;96:1457-62 (WD0600)

Related Products

Product NameProduct CodeSupplier 
Beta-Site APP-Cleaving Enzyme 2 (NT) Blocking PeptideLEI-B367Leinco Technologies Summary Details